INS and polycystic ovary syndrome: In this regard, it was reported that α-trinositol (D-myo-inositol-1,2,6-trisphosphate), a synthetic inositol phosphate analog with significant anti-inflammatory properties [22] showed good safety and efficacy in decreasing IR in PCOS patients by acting as an insulin-sensitizer [23–26].